A vaccine in development would be the first proactive treatment for overdose and fentanyl addiction, if approved.

Exploring clinical development plan options including a controlled human infection model (CHIM) and a Phase 2/3 adaptive field studyExpect to ...

Lifordi Immunotherapeutics and other biotechnology companies are using antibodies to precisely target drugs in the body.

The U.S. Food and Drug Administration has approved Omeros' drug for a dangerous transplant complication in adults and ...

A multicenter study led by UC Davis Health has tested a new treatment designed to improve care for people with a rare liver ...

Researchers at the University of Sharjah are exploring a promising approach that could enhance the immune system's ability to ...

The patient, who died on December 14, was originally enrolled in a Phase III study in 2022 and transitioned into an extension phase in 2023.

FcRn blockers are approved for other indications: efgartigimod for adults with generalized myasthenia gravis and in ...

Multiple myeloma is an incurable plasma cell malignancy despite major therapeutic advances. A recent review by Chinese ...

Scientists present a new approach that could empower the immune system to combat cancer cells and pave the way for new ...

Expanding bispecific antibody access for multiple myeloma involves collaboration between academic centers and community ...

Veligrotug, an IGF-1R inhibitor, is under FDA Priority Review for thyroid eye disease based on positive phase 3 trial data.